Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 2Breast 2

Conditions

Overweight 2Obesity 2Breast Neoplasms 2Glioma 1Glioblastoma 1

Interventions

Metformin 14Exercise 14Resistance Training 5Nutrition Assessment 5Methods 5Exenatide 5Diet 5Diet Therapy 4Surveys and Questionnaires 3Sugars 3Early Intervention, Educational 3Counseling 3Caloric Restriction 3exemestane 2Yoga 2Vitamin D 2Nutritional Status 2Naltrexone 2Mindfulness-Based Stress Reduction 2Liraglutide 2Educational Status 2Docosahexaenoic Acids 2Diet, Mediterranean 2Cognitive Behavioral Therapy 2Bupropion 2Blood Specimen Collection 2sibutramine 1rosiglitazone-metformin combination 1penclomedine 1licogliflozin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Obesity × Naltrexone × Clear all
NCT04499950 2025-03-06

A-NEW

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed
53 enrolled 14 charts
BreastOther

Breast Neoplasms, Obesity, Overweight

NCT03581630 2018-08-29

Effects of Mediterranean Diet and Naltrexone/Bupropion Treatment in Obese Breast Cancer Patients

Gangnam Severance Hospital

Phase NA Completed
72 enrolled
BreastOther

Breast Neoplasms, Obesity, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡